Biosion scientists believe that great medicines come from the synergy of great science, cutting-edge technologies, and superior craftmanship.
DRUG DESIGN IS FUNDAMENTAL TO SUCCESS

Drug design, often referred to as rational drug design, is the inventive process of finding new medications based on the knowledge and biology of a drug target and its involvement in causing disease. Biosion scientists have developed fit-for-purpose innovative medicines using our proprietary discovery platforms with the goal to cure life-threatening diseases.

CORE STRENGTHS OF BIOSION
  • Biology
    Understanding Disease Biology & Mechanism of Action
    Target ID & Profiling
    Disease Association
    Target Validation
  • Discovery
    H

    3

    Platform
    -High-Throughput -High-Content -High-Efficiency
    Robust Generation& ldentification of Lead Candidates with Superior Properties
  • Fit for Purpose
    mAb
    -FIC or BIC
    single target
    -ADC Nextgen
    -Biparatopic
    Bi-target
    -2-in-1 Combo -Bi-specifics
INTEGRATED PROPRIETARY DISCOVERY PLATFORM GENERATING INNOVATIVE THERAPEUTICS.

Biosion scientists have built an integrated discovery platform to understand target biology and mechanism of action, to identify and characterize superior lead candidates, and to create fit-for-purpose therapeutics.

Copyright © 2022. Biosion All rights reserved. 苏ICP备2022027163号
Biosion scientists believe that great medicines come from the synergy of great science, cutting-edge technologies, and superior craftmanship.
DRUG DESIGN IS FUNDAMENTAL TO SUCCESS

Drug design, often referred to as rational drug design, is the inventive process of finding new medications based on the knowledge and biology of a drug target and its involvement in causing disease. Biosion scientists have developed fit-for-purpose innovative medicines using our proprietary discovery platforms with the goal to cure life-threatening diseases.

CORE STRENGTHS OF BIOSION
  • Biology
    Understanding Disease Biology & Mechanism of Action
    Target ID & Profiling
    Disease Association
    Target Validation
  • Discovery
    H

    3

    Platform
    -High-Throughput -High-Content -High-Efficiency
    Robust Generation& ldentification of Lead Candidates with Superior Properties
  • Fit for Purpose
    mAb
    -FIC or BIC
    single target
    -ADC Nextgen
    -Biparatopic
    Bi-target
    -2-in-1 Combo -Bi-specifics
INTEGRATED PROPRIETARY DISCOVERY PLATFORM GENERATING INNOVATIVE THERAPEUTICS.

Biosion scientists have built an integrated discovery platform to understand target biology and mechanism of action, to identify and characterize superior lead candidates, and to create fit-for-purpose therapeutics.

Copyright © 2022. Biosion All rights reserved. 苏ICP备2022027163号